Avastin News Monitoring

Get by Email • RSS

Published on Mar 24, 2025

Angiogenesis and the eye: A Journey to unlock the secrets of blood vessel growth

Angiogenesis is the growth of blood vessels from the existing vasculature. The process occurs throughout life in both health and disease, beginning in utero and continuing on through old age. It is essential for normal growth and wound healing. No …

Source: Ophthalmology Times - Label Pending
Published on Mar 21, 2025

Emerging ADCs, Biomarker-Driven Treatments, and Diagnostic Advancements Take Center Stage at the SGO Annual Meeting

The 2025 SGO Annual Meeting on Women’s Cancer concluded on Monday after 4 days of data-driven discussions on evolving treatment paradigms, emerging therapeutics, and critical advancements across ovarian, endometrial, cervical, and other gynecologic …

Source: OncLive - Label Pending
Published on Mar 20, 2025

Pembrolizumab Plus Bevacizumab Shows Promise for Melanoma Brain Metastases

Anti-VEGF therapy with bevacizumab (Avastin) may enhance the clinical activity of the PD-1 inhibitor pembrolizumab (Keytruda) in patients with untreated melanoma brain metastases (MBM), according to findings from a phase 2 study (NCT02681549) published in …

Source: Targeted Oncology - Label Pending
Published on Mar 24, 2025

NMPA Approves sNDA for Toripalimab Plus Bevacizumab in Advanced HCC

China’s National Medical Products Administration (NMPA) has approved the supplemental new drug application (sNDA) for first-line toripalimab (Loqtorzi) in combination with bevacizumab (Avastin) for the treatment of patients with unresectable or metastatic …

Source: OncLive - Label Pending
Published on Mar 24, 2025

Opthea on the brink after Phase-3 failure

Published on March 24, 2025 Australia’s visionary eye-health company Opthea, which raised almost $1 billion to bring its eye injection to market, is fighting for survival today after the failure of its first Phase-3 trial. Opthea’s chief innovation officer …

Source: Forbes Australia - Label Pending
Published on Mar 22, 2025

Dr Cho on Niraparib Rechallenge Plus Bevacizumab in Platinum-Sensitive, Recurrent Ovarian Cancer

"As of the data cutoff, the median follow-up period was 11.8 months, and the primary end point of the estimated 6-month PFS rate was 68%. The median PFS was 11.5 months." Hyun-Woong Cho, MD, PhD, Department of Obstetrics and Gynecology, Korea …

Source: OncLive - Label Pending
Published on Mar 21, 2025

Second CRL for Rivoceranib/Camrelizumab for Unresectable HCC

Despite receiving an initial complete response letter (CRL) on May 16, 2024,1 the resubmitted new drug application for rivoceranib (Elevar Therapeutics) plus camrelizumab (Antiengene Corporation) to treat unresectable hepatocellular carcinoma (HCC) …

Source: The American Journal of Managed Care - Neutral
Published on Mar 21, 2025

Intravitreal Bevacizumab Alone Vs Combined With Topical Timolol-Dorzolamide or Dorzolamide for Diabetic Macular Edema: A ...

Introduction Diabetic macular edema (DME) is a serious complication of diabetes mellitus characterized by excessive accumulation of fluid within retinal layers of the macula. DME is the leading cause of vision loss among individuals with diabetes.1–3 …

Source: Dove Medical Press - Neutral

06 days 16:47:43

Featured Releases

Got News to Share? · Submit · See All

Published on March 25, 2025 - 06:30 GMT

Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan

- Alumis to receive $40 million in upfront and near-term co-development payments, with potential for approximately $140 million in additional milestone and field option payments, plus tiered royalties on future sales -Deal underscores the commercial …

Distribution channels: Technology ...
Published on March 25, 2025 - 10:01 GMT

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line data anticipated in 2H 2026 4WARD trial protocol refined, increasing confidence in successful outcome 2024 …

Distribution channels:

Published on March 25, 2025 - 06:00 GMT

NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel ...

Company presented clinical and preclinical data at the MDA Conference last week in Dallas, Texas Oral presentation included data from MuSK-MG rat model depicting increases in muscle function and improvements in the structural integrity of the neuromuscular …

Distribution channels: Media, Advertising & PR, Technology ...
Published on March 25, 2025 - 03:13 GMT

Lawsuit Notice: Investors who hold Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares should contact the Shareholders ...

SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Investors who purchased shares of Regeneron Pharmaceuticals, …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on March 24, 2025 - 13:44 GMT

Peptic Ulcer Drugs Market to Reach USD 54.8 Billion by 2032 – Persistence Market Research

The global peptic ulcer drugs market is set to grow from USD 42.6 Bn in 2025 to USD 54.8 Bn by 2032, registering a CAGR of 3.2% during the forecast period. LOS ANGELES, CA, UNITED STATES, March 24, 2025 /⁨EINPresswire.com⁩/ -- Peptic ulcers are a …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 00:05 GMT

Nxera Pharma’s Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use Disorder

Tokyo, Japan and Cambridge, UK, 25 March 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of TMP-301, a potent, selective and orally available mGluR5 negative …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on March 24, 2025 - 23:12 GMT

American Botanical Pharmacy - 562180 - 10/30/2018

Product: Biologics Cosmetics Drugs Blood Products Gene Therapy Deodorant Face Paint Antibiotic Resistance Compounding Issue: Topics Premarket Public Awareness Recipient: Recipient Name Dr. Richard Schulze American Botanical Pharmacy 4114 Glencoe Ave Marina …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on March 24, 2025 - 21:36 GMT

Bingbing Pharmaceutical Co., Ltd - 584327 - 10/03/2019

Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Mr. Zhimin Yu Recipient Title President Bingbing Pharmaceutical Co., Ltd No. 698 Bingbing Road Economic Development Zone Shiyan Shi Hubei Sheng, 442500 China Issuing Office: Center for Drug …

Distribution channels: Healthcare & Pharmaceuticals Industry

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 796,903,962 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on March 25, 2025 - 11:00 GMT

Dean Melissa Perry appointed to prestigious National Academies of Sciences, Engineering, and Medicine Committee

Perry appointed to NASEM Committee on Clinical Follow-Up and Care for Those Impacted by the JP-5 Releases at Red Hill. FAIRFAX, VA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- As a widely respected researcher and public health leader, …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

LarmorBio Announces Addition of Multiple New Board Members and Senior Executive Hires

Company Prepares to Scale Business with Proprietary Microscale Magnetic Resonance Technology BOSTON, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- LarmorBio, a Massachusetts Institute of Technology (MIT) start-up pioneering the use of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

Enkrypt AI Launches New Multimodal AI Security Solution to Safeguard Text, Image, and Voice AI Systems

Innovative solution secures multimodal AI systems from emerging security, bias, and compliance risks BOSTON, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Enkrypt AI, a leader in AI security and compliance – is proud to announce the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on March 25, 2025 - 11:00 GMT

CMTA’s $300K Investment in CRISPR for CMT2A

CMTA invests $300K in CRISPR gene editing for CMT2A at UCSF’s Gladstone Institutes, targeting MFN2 mutations to restore nerve function. GLENOLDEN, PA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:45 GMT

Feroot Launches PaymentGuard AI: Automated PCI DSS 4 Compliance for Websites with E-commerce Payment Webpages.

PaymentGuard AI by Feroot Security: Automating PCI DSS 4 Compliance with Requirements 6.4.3 and 11.6.1 for SAQ D and SAQ A-EP E-Commerce Merchants. TORONTO, CANADA, March 25, 2025 /⁨EINPresswire.com⁩/ -- Feroot Security, a leader in cybersecurity …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:45 GMT

PUSH for Empowered Pregnancy Launches #MomentForStillness to Honor Babies Born Still and Demand Urgent Action

A Nationwide Call to Address Preventable Stillbirths Begins March 25th at Noon ET NEW YORK, NY, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- PUSH for Empowered Pregnancy is launching the #MomentForStillness campaign at noon ET on Tuesday, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:18 GMT

TravelingWiki Foundation Launches 'Card For a Cause' to Leverage Sports Cards for Free Non Visible Disability Resources

TravelingWiki Now Offers Free Resources in English, Spanish, French, German, Mandarin, Japanese, Hebrew, Arabic, Portuguese, Hindi, Twi, Vietnamese & Russian DES MOINES, IA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- TravelingWiki …

Distribution channels: Aviation & Aerospace Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:00 GMT

PhenoBiome Welcomes New Leadership and Validates Breakthrough Microbiome Modulation

Brian Russon Named CEO, Kait Mikes Appointed COO as Company Advances Clinical Validation of Predictive Platform PALM SPRINGS, CA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- PhenoBiome, Inc., a pioneering leader in personalized …

Distribution channels: Business & Economy, Food & Beverage Industry ...
Published on March 25, 2025 - 09:45 GMT

Florida Mesothelioma Victims Center Has Endorsed the Gori Law Firm for a Former Power Plant Worker with Just Diagnosed ...

TAMPA , FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Florida Mesothelioma Victims Center says, "We have endorsed, and we highly recommend the Gori Law Firm for a former power plant worker with just diagnosed mesothelioma or …

Distribution channels: Automotive Industry, Building & Construction Industry ...
Published on March 25, 2025 - 09:43 GMT

OmnySense to Target Oncology Patients as Initial Focus for Its Transformative Personal Health-Assessment Solution

19m Americans have cancer. Unplanned acute visits drive nearly half the costs-creating a major unmet need and opportunity for innovative solutions TEL AVIV, ISRAEL, March 25, 2025 /⁨EINPresswire.com⁩/ -- OmnySense, an innovative digital health …

Distribution channels: Banking, Finance & Investment Industry, Emergency Services ...
Published on March 25, 2025 - 08:17 GMT

RSU Research Week Opening Session highlights the interaction between medicine, technology, and behavioural science

RSU Research Week 2025 opened on 24 March with an ambitious plenary session focusing on the role of research, technology, and the human factor in healthcare. RIGA, LATVIA, March 25, 2025 /⁨EINPresswire.com⁩/ -- RSU Research Week 2025 opened on 24 …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 08:09 GMT

Dan Pitulia Appointed as Group CEO of the Atlas Antibodies Group

The Board of Atlas Antibodies Group is pleased to announce the appointment of Dan Pitulia as the new Group Chief Executive Officer (CEO). STOCKHOLM, SWEDEN, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Board of Atlas Antibodies Group is pleased to announce …

Distribution channels: Business & Economy, Chemical Industry ...
Published on March 25, 2025 - 07:36 GMT

A' Wellness, Health Promotion, and Preventive Care Design Award Announces Comprehensive Prize Package for 2024

The prestigious A' Wellness, Health Promotion, and Preventive Care Design Award reveals an extensive array of benefits for 2024 competition laureates COMO, CO, ITALY, March 25, 2025 /⁨EINPresswire.com⁩/ -- The A' Wellness, Health Promotion …

Distribution channels: Business & Economy, Consumer Goods ...
Published on March 25, 2025 - 05:24 GMT

Unlocking the Potential of Tofacitinib: New Frontiers in Treating Skin Disorders

BRADENTON, FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Skin disease related to immune system problems can be a challenge to treat. A new drug, Tofacitinib has gained attention for its therapeutic effects in autoimmune and inflammatory …

Distribution channels: Beauty & Hair Care, Education ...
Published on March 25, 2025 - 05:08 GMT

Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA

Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA: Empowering young children with autism through individualized therapy. LANCASTER, PA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Acclaim Autism is thrilled to …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 24, 2025 - 23:15 GMT

Helvetic Dental Clinics en Hongrie célèbre une année record en 2024 en tant que meilleure clinique dentaire de Budapest

Helvetic Dental Clinics, la meilleure clinique dentaire en Hongrie, termine 2024 sur un bilan record et agrandit sa capacité avec l’ajout de quatre fauteuils. BUDAPEST, BUDAPEST, HUNGARY, March 25, 2025 /⁨EINPresswire.com⁩/ -- Helvetic Dental …

Distribution channels: Beauty & Hair Care, Business & Economy ...
Published on March 24, 2025 - 23:12 GMT

Chasin A Dream Foundation’s Annual Gala Raises Over $550,000 for Local Children Battling Life-Threatening Illnesses

The Jupiter based foundation's annual gala was an unforgettable evening of generosity and impact, breaking a record with $550,000 raised. JUPITER, FL, UNITED STATES, March 24, 2025 /⁨EINPresswire.com⁩/ -- Chasin A Dream Foundation’s annual …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...
Published on March 24, 2025 - 22:57 GMT

Study Validates Effectiveness of KYAN Tech's Platform for Combination Therapy Prediction and Target Discovery in Sarcoma

Groundbreaking study published in npj Precision Oncology highlights Optim.AI’s potential to revolutionize personalized cancer treatment strategies SINGAPORE, SINGAPORE, March 24, 2025 /⁨EINPresswire.com⁩/ -- KYAN Technologies Pte. Ltd. (“KYAN”) …

Distribution channels: Companies, Education ...
Published on March 25, 2025 - 10:30 GMT

Teleflex Announces Updated Clinical Study Data Presented at the European Association of Urology (EAU) Congress

WAYNE, Pa., March 25, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that new findings from the CLEAR study were presented at the 40th Annual European Association of Urology ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:30 GMT

Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) ...

Based on overall survival data observed in interim analysis in platinum-resistant ovarian cancer, Mural will not progress trial to final analysis Continued demonstration of favorable tolerability profile generally consistent with previously reported data; …

Distribution channels: Healthcare & Pharmaceuticals Industry ...